Microbicide Gel: Reduced Risk of HIV and Herpes
Infections in Women, Study Shows
ScienceDaily (July 20, 2010) — Researchers have achieved an important scientific breakthrough in the fight against HIV and genital herpes
with a vaginal gel that significantly reduces a woman's risk of being infected with these viruses. The results of the ground-breaking safety and effectiveness study of an antiretroviral microbicide gel study were reported by the Centre for the AIDS Programme of Research in South Africa (CAPRISA) at the XVIII International AIDS Conference in Vienna, Austria.
Tenofovir works by preventing HIV from growing inside human cells. Taken in pill form, tenofovir is a common component of various three-drug cocktails that are used to treat HIV infections. The new results now indicate that tenofovir formulated as a topical gel and inserted into the female genital tract also has great promise for use in HIV and herpes simplex virus type-2
Read complete article @http://www.sciencedaily.com/releases/2010/07/100719142444.htmRelated ArticlesGenital Herpes - Natural TreatmentsCondom Use Lowers Men's, Women's Risk of Contracting GenitalWomen InfertilityGenital Herpes Symptoms in Men, Are You Infected?Causes of genital herpes out break- as explained in ayurvedaOral sex raises risk of herpes infectionAloevera and genital herpesSo How Do You Get Genital Herpes?Microbicide Gel: Reduced Risk of HIV and Herpes Infections
Go to Free Ayurveda Consultations